Cite
HARVARD Citation
de Wild, S. et al. (2022). De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study. Lancet oncology. 23 (9), pp. 1201-1210. [Online].